HIL Applied Medical

Company Overview

Snapshot

Founded in November 2010 by Arie Zigler, HIL Applied Medical operated with 11–50 employees. The company raised a total of $36.82 million across 12 funding rounds from 4 investors. A significant milestone for the company was its acquisition of Nanolabz in May 2016.

Business overview

HIL Applied Medical develops ultra-compact, high-performance accelerators for proton therapy, utilizing a patented, laser-based, nanotech-enabled approach to particle acceleration. This technology aims to facilitate cost-effective, single-room proton therapy systems. The company also focuses on ultra-compact beam delivery solutions, including beamlines and rotating gantries, designed to leverage the unique properties of laser-accelerated proton beams. HIL Applied Medical's technology is intended to provide expandable, add-on single-room solutions with advanced clinical capabilities such as 360-degree rotation, integrated imaging, pencil-beam scanning, IMPT, gating, and adaptive therapy, primarily serving the healthcare industry and hospitals.

Strategic signal

In January 2022, HIL Applied Medical and Proton International were awarded a $900K grant from the BIRD Foundation to advance an ultra-compact, affordable proton beam therapy solution for cancer. This grant signals continued external validation and support for HIL's innovative approach to making proton therapy more accessible and cost-effective, which could significantly impact cancer treatment modalities.

Company Intelligence Q&A

What is HIL Applied Medical's core technology?

HIL Applied Medical develops ultra-compact, high-performance accelerators for proton therapy, utilizing a patented, laser-based, nanotech-enabled approach to particle acceleration.

When was HIL Applied Medical founded?

HIL Applied Medical was founded in November 2010.

What grant funding did HIL Applied Medical receive in 2022?

In January 2022, HIL Applied Medical and Proton International were awarded a $900K grant from the BIRD Foundation to advance an ultra-compact, affordable proton beam therapy solution for cancer.

What was the strategic significance of the University of Nevada, Reno collaboration?

In August 2017, a university collaboration led HIL Applied Medical to name Reno as its North American headquarters, indicating a strategic expansion of its operational footprint.